Somarelli Presents on Cancer Therapy Resistance (5.5.20)

Jason Somarelli

The Children’s Health and Discovery Initiative (CHDI) at the Duke Department of Pediatrics is hosting Duke Cancer Institute molecular biologist Jason Somarelli, PhD, for a virtual seminar on "Cancer, convergence, and competition: Leveraging evolutionary dynamics to overcome cancer therapy resistance" on Tuesday, May 5, from 1 p.m. to 2 p.m.

In this talk geared toward undergraduate students, graduate students and a lay audience, Somarelli will give a broad overview of cancer as a problem of all multicellular organisms, and also discuss some of his research team's recent findings on therapy resistance in osteosarcoma in children. (Last year, Somarelli, with Thomas Schultz, PhD, received a $40,000 TriCEM-CHDI Pilot Research Grant from the Triangle Center for Evolutionary Medicine and the Children’s Health and Discovery Initiative for his project "Fitness Bottlenecks as a Therapeutic Vulnerability in Osteosarcoma.")

Join the Talk:

Somarelli, an assistant professor in the Department of Medicine (for Medical Oncology), researches the mechanisms behind cancer metastasis. As director of research for the Duke Comparative Oncology Group, he co-leads a team focused on understanding pediatric cancers through the lens of comparative and evolutionary biology. (Somarelli is also director of the Duke Scholars in Marine Medicine Program, an undergraduate program in cross-disciplinary mentored research on the marine environment and human health.)